Next, transcriptome analysis by microarray was used to explore candidate mechanisms and identify potential molecular pathways that may contribute to the effects of Trem2 deficiency on the aggravated neuronal pathology and reduced microglial reactivity observed during CNS prion disease. This evidence concerns the gene TREM2 and prion disease.